Biodexa Pharmaceuticals Plc (BDRX)
2.16
+0.07
(+3.35%)
USD |
NASDAQ |
Jan 15, 11:10
Biodexa Pharmaceuticals SG&A Expense (TTM): 5.354M for June 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| NuCana Plc | 9.964M |
| Autolus Therapeutics Plc | 129.58M |
| Mereo BioPharma Group Plc | 25.26M |
| Bicycle Therapeutics Plc | 80.05M |
| Adaptimmune Therapeutics Plc | 90.49M |